Status: Recruiting
Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
This is a prospective, multicenter, randomized, double-blind, parallel, phase IV study designed to evaluate the safety and efficacy of sovateltide (PMZ-1620, IRL-1620) as a potential treatment for cerebral ischemic stroke.
Participants needed: 160
Trial details
Phase: Phase 4Age: 18-78Biological sex: AllType: InterventionalSponsor: Pharmazz, Inc.Updated: Dec 31, 2025Locations: 6
Eligibility criteria
Adult males or females aged 18 years through 78 years (have not had their 79th b... [+5]
Patients receiving endovascular therapy or is a candidate for any surgical inter... [+5]